| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
IRON
Disc Medicine
|
Jun 16, 2026 | BUY |
Strong Buy
+20.3% avg upside
21 analysts
|
$85.00
20.02% Upside
|
· |
|
HALO
Halozyme
|
Jun 15, 2026 | BUY |
Strong Buy
-13.7% avg upside
20 analysts
|
$93.00
35.59% Upside
|
-3.8% |
|
MPLT
MapLight Therapeutics, Inc.
|
Jun 11, 2026 | BUY |
Strong Buy
+32.5% avg upside
11 analysts
|
$34.00
18.02% Upside
|
-10.5% |
|
CGEM
Cullinan Management
|
Jun 07, 2026 | BUY |
Strong Buy
+125.7% avg upside
15 analysts
|
$30.00
99.52% Upside
|
+8.7% |
|
ABSI
AbSci
|
Jun 02, 2026 | HOLD |
Strong Buy
+37.3% avg upside
18 analysts
|
$4.10
44.65% Downside
|
+7.1% |
|
BBIO
BridgeBio Pharma
|
May 27, 2026 | BUY |
Strong Buy
+38.3% avg upside
34 analysts
|
$98.00
47.98% Upside
|
+1.4% |
|
DNLI
Denali Therapeutics
|
May 26, 2026 | BUY |
Strong Buy
+60.2% avg upside
24 analysts
|
$35.00
50.06% Upside
|
+13.2% |
|
BBOT
BridgeBio Oncology Therapeutics
|
May 15, 2026 | BUY |
Strong Buy
+231.7% avg upside
10 analysts
|
$18.00
138.16% Upside
|
-9.8% |
|
CGON
CG Oncology, Inc.
|
May 15, 2026 | BUY |
Strong Buy
+41.1% avg upside
17 analysts
|
$93.00
52.17% Upside
|
-11.2% |
|
RXRX
Recursion Pharmaceuticals
|
May 14, 2026 | HOLD |
Buy
+147.3% avg upside
12 analysts
|
$5.50
70.34% Upside
|
+2.3% |
|
GENB
Generate Biomedicines, Inc.
|
May 14, 2026 | BUY |
Strong Buy
+76.8% avg upside
6 analysts
|
$22.00
51.90% Upside
|
· |
|
CTNM
Contineum Therapeutics, Inc. Class A
|
May 14, 2026 | HOLD |
Strong Buy
+70.7% avg upside
8 analysts
|
$16.00
33.98% Upside
|
-9.8% |
|
SDGR
Schrodinger
|
May 14, 2026 | HOLD |
Strong Buy
+80.6% avg upside
14 analysts
|
$17.00
7.95% Upside
|
+14.5% |
|
ARGX
Argenx Se
|
May 08, 2026 | BUY |
Strong Buy
-15.9% avg upside
46 analysts
|
$1170.00
33.26% Upside
|
+12.8% |
|
ONC
BeOne Medicines
|
May 07, 2026 | BUY |
Strong Buy
+28.6% avg upside
28 analysts
|
$395.00
46.29% Upside
|
-17.1% |
|
EXEL
Exelixis
|
May 06, 2026 | HOLD |
Strong Buy
-21.1% avg upside
33 analysts
|
$50.00
3.73% Downside
|
+9.1% |
|
NBIX
Neurocrine
|
May 06, 2026 | HOLD |
Strong Buy
+7.8% avg upside
37 analysts
|
$191.00
20.69% Upside
|
+8.7% |
|
BMRN
BioMarin Pharmaceutical
|
May 06, 2026 | BUY |
Strong Buy
+72.7% avg upside
52 analysts
|
$119.00
117.63% Upside
|
+0.8% |
|
AXSM
Axsome Therapeutics
|
May 05, 2026 | HOLD |
Strong Buy
-10.6% avg upside
28 analysts
|
$242.00
3.30% Downside
|
+12.9% |
|
JAZZ
Jazz Pharmaceuticals
|
May 05, 2026 | BUY |
Strong Buy
-1.8% avg upside
35 analysts
|
$245.00
9.15% Upside
|
+8.6% |
|
ALEC
Alector
|
May 04, 2026 | SELL |
Hold
+537.9% avg upside
14 analysts
|
$2.00
14.20% Upside
|
+13.9% |
|
ERAS
Erasca
|
Mar 16, 2026 | HOLD |
Strong Buy
+38.6% avg upside
14 analysts
|
$12.00
12.26% Downside
|
+3.5% |
|
EIKN
Eikon Therapeutics, Inc.
|
Mar 03, 2026 | BUY |
Strong Buy
+147.2% avg upside
5 analysts
|
$32.00
232.91% Upside
|
· |
|
IMCR
Immunocore Holdings
|
Feb 26, 2026 | HOLD |
Strong Buy
+124.5% avg upside
22 analysts
|
$40.00
39.83% Upside
|
-12.4% |
|
ACAD
ACADIA Pharmaceuticals
|
Feb 26, 2026 | HOLD |
Strong Buy
+66.0% avg upside
42 analysts
|
$26.00
20.33% Upside
|
-12.3% |
|
CNTA
Centessa Pharmaceuticals
|
Nov 12, 2025 | BUY |
Buy
-14.4% avg upside
19 analysts
|
$27.00
32.56% Downside
|
+49.3% |
|
AU:SIG
Sigma Healthcare Ltd
|
Aug 28, 2025 | BUY |
Buy
+201.9% avg upside
6 analysts
|
$3.30
19.11% Upside
|
· |
|
CERT
Certara
|
Jul 02, 2025 | HOLD |
Buy
+133.3% avg upside
21 analysts
|
$16.00
188.75% Upside
|
-47.3% |
|
AU:MPL
Medibank Private
|
Feb 12, 2025 | HOLD |
Hold
-19.4% avg upside
1 analyst
|
$3.95
19.35% Downside
|
· |
|
RMD
Resmed
|
Aug 01, 2024 | HOLD |
Buy
+25.4% avg upside
27 analysts
|
— | +31.3% |
|
AU:RMD
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
|
Jun 24, 2024 | BUY |
Strong Buy
+58.0% avg upside
11 analysts
|
$33.70
26.24% Upside
|
· |
|
AU:CSL
CSL
|
Jun 12, 2024 | BUY |
Strong Buy
+63.9% avg upside
15 analysts
|
$310.00
178.63% Upside
|
· |
|
AU:SHL
Sonic Healthcare Limited
|
May 22, 2024 | BUY |
Buy
+29.7% avg upside
11 analysts
|
$31.65
58.69% Upside
|
· |
|
AU:ANN
Ansell
|
Apr 09, 2024 | HOLD |
Buy
+12.4% avg upside
9 analysts
|
$24.14
19.54% Downside
|
· |
|
AU:COH
Cochlear
|
Mar 21, 2024 | SELL |
Hold
+51.8% avg upside
15 analysts
|
$256.00
123.32% Upside
|
· |
|
AU:HLS
Healius Limited
|
Feb 28, 2024 | SELL |
Sell
+109.7% avg upside
10 analysts
|
$1.30
217.10% Upside
|
· |
|
AU:NHF
NIB Holdings Ltd
|
Feb 27, 2024 | HOLD |
Hold
+5.7% avg upside
1 analyst
|
$7.35
5.66% Upside
|
· |
|
AU:MVF
Monash IVF Group Ltd
|
Feb 26, 2024 | BUY |
Strong Buy
+40.8% avg upside
4 analysts
|
$1.65
129.25% Upside
|
· |
|
AU:RHC
Ramsay Health Care
|
Nov 28, 2023 | HOLD |
Hold
+1.7% avg upside
14 analysts
|
$51.60
31.41% Upside
|
· |
|
AU:IDX
Integral Diagnostics Ltd.
|
Aug 28, 2023 | SELL |
Strong Buy
+55.6% avg upside
10 analysts
|
$2.75
40.98% Upside
|
· |
|
SKHHY
Sonic Healthcare
|
Aug 24, 2021 | BUY |
Buy
5 analysts
|
— | -18.6% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.